HM
Hemostemix Inc
HMTXF · OTC
$0.05 -1.33% (-$0.00)
1M +7.42%
Market Cap $14.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.03
43.7% downside
Trenutna cena
$0.053
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HMTXF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 336.74%
Asset turnover 0.00x
ROA 1,758.21%
Debt
0 /100
High Current ratio 0.13x
Int. coverage -11.72x
Debt/Equity N/A
Stability
62 /100
Moderate Beta 0.61x
Profitable years 0
EPS volatility 33.77%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HMTXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas A. Smeenk
Employees
488
Headquarters
Calgary
Prihajajoči dogodki
27 NOV.
Earnings
Upcoming earnings report